The US glioma diagnosis and treatment market — the commercial ecosystem for glioma diagnostic technologies, surgical tools, radiation platforms, chemotherapy, targeted therapies, immunotherapy, and clinical trials addressing the most common primary malignant brain tumors — reflects both the clinical urgency of brain cancer and the extraordinary scientific evolution reshaping glioma...